Search research articles

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Non-Hodgkin's lymphomas: immunologic prognostic studies.

L Hadzi-Pecova¹, G Petrusevska, A Stojanovic

¹Department of Hematology, Clinical Centre, Skopje, R. Macedonia. lhpecova@mt.net.mk

|October 9, 2007

Summary

This study introduces a New Prognostic Index (New-PI) for Non-Hodgkin's Lymphoma (NHL) that improves upon the standard International Prognostic Index (IPI). The New-PI incorporates molecular markers, offering more accurate outcome prediction for NHL patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tumor necrosis factor gene polymorphisms in adult patients with autoimmune hemolytic anemia.

International journal of laboratory hematology·2017

Same author

Novel RET mutations in macedonian patients with medullary thyroid carcinoma: genotype-phenotype correlations.

Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)·2015

Same author

Single nucleotide polymorphisms of the inflamatory cytokine genes: interleukin-1B, tumor necrosis factors-A and tumor necrosis factor-B in adult patients with immune thrombocytopenia.

Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)·2015

Same author

Sentinel lymph node detection in breast cancer - first experience.

Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)·2015

Same author

MicroRNAs in Breast Cancer -Our Initial Results.

Balkan journal of medical genetics : BJMG·2013

Same author

Perindopril treatment in streptozotocin induced diabetic nephropaty.

Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)·2013

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Area of Science:

Hematology
Oncology
Immunology

Background:

Non-Hodgkin's Lymphoma (NHL) is a heterogeneous malignancy with varied clinical presentations and outcomes.
The International Prognostic Index (IPI) is a standard tool for predicting NHL prognosis based on clinical factors.
IPI limitations include its failure to account for molecular abnormalities influencing disease aggressiveness.

Purpose of the Study:

To evaluate the clinical significance and prognostic value of novel immunologic markers in NHL.
To develop an improved prognostic index by integrating these markers with existing clinical factors.
To compare the predictive accuracy of the new index against the standard IPI.

Main Methods:

Retrospective analysis of 136 NHL patients' clinical and molecular data.

More Related Videos

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Related Experiment Videos

Last Updated: Jul 11, 2026

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Immunohistochemistry was employed to assess the expression of specific immunologic prognostic markers in tumor tissues.

Multivariate analyses and survival analyses were conducted to identify independent prognostic factors and compare predictive models.

Main Results:

The standard IPI demonstrated prognostic significance for response rate and survival in the studied cohort.
High serum lactate dehydrogenase, poor performance status, high Ki67 proliferation index (>60%), and loss of Collagen IV expression were identified as significant predictors of poor survival.
The newly developed Prognostic Index (New-PI), incorporating these four factors, showed superior accuracy in predicting patient outcomes compared to the standard IPI (p < 0.001).

Conclusions:

The standard IPI is a useful prognostic tool for NHL, but its predictive power can be enhanced.
Incorporating novel cellular markers like Ki67 and Collagen IV expression into risk stratification significantly improves outcome prediction for NHL patients.
The New-PI offers a more accurate and refined approach to risk stratification in NHL, aiding in personalized treatment strategies.